Trial intelligence / Profile preview

Desmopressin melt therapy in nocturnal polyuria patients: PK/PD study

2011-004540-22Phase 4Completed

Sponsor
Ghent University Hospital
Start
Sep 2011
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of desmopressin in nocturnal polyuria (NP) and nocturia, sponsored by Ghent University Hospital. Primary endpoint: Blood levels of desmopressin. Started Sep 2011; status: completed.

02

Drugs

desmopressin
03

Conditions

nocturnal polyuria (NP)nocturia

Beyond the preview

Go deeper on 2011-004540-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004540-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call